120 related articles for article (PubMed ID: 15102660)
1. Matrix metalloproteinase 3 polymorphism: a predictive factor of response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Blons H; Gad S; Zinzindohoué F; Manière I; Beauregard J; Tregouet D; Brasnu D; Beaune P; Laccourreye O; Laurent-Puig P
Clin Cancer Res; 2004 Apr; 10(8):2594-9. PubMed ID: 15102660
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
Chaudhary AK; Singh M; Bharti AC; Singh M; Shukla S; Singh AK; Mehrotra R
BMC Cancer; 2010 Jul; 10():369. PubMed ID: 20630073
[TBL] [Abstract][Full Text] [Related]
4. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma.
Lièvre A; Milet J; Carayol J; Le Corre D; Milan C; Pariente A; Nalet B; Lafon J; Faivre J; Bonithon-Kopp C; Olschwang S; Bonaiti-Pellié C; Laurent-Puig P;
BMC Cancer; 2006 Nov; 6():270. PubMed ID: 17125518
[TBL] [Abstract][Full Text] [Related]
6. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma.
Hashimoto T; Uchida K; Okayama N; Imate Y; Suehiro Y; Hamanaka Y; Ueyama Y; Shinozaki F; Yamashita H; Hinoda Y
Cancer Lett; 2004 Jul; 211(1):19-24. PubMed ID: 15194213
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H
PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis.
Bradbury PA; Zhai R; Hopkins J; Kulke MH; Heist RS; Singh S; Zhou W; Ma C; Xu W; Asomaning K; Ter-Minassian M; Wang Z; Su L; Christiani DC; Liu G
Carcinogenesis; 2009 May; 30(5):793-8. PubMed ID: 19321798
[TBL] [Abstract][Full Text] [Related]
9. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
Sherva R; Ford CE; Eckfeldt JH; Davis BR; Boerwinkle E; Arnett DK
Stroke; 2011 Feb; 42(2):330-5. PubMed ID: 21183746
[TBL] [Abstract][Full Text] [Related]
12. p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.
Cabelguenne A; Blons H; de Waziers I; Carnot F; Houllier AM; Soussi T; Brasnu D; Beaune P; Laccourreye O; Laurent-Puig P
J Clin Oncol; 2000 Apr; 18(7):1465-73. PubMed ID: 10735894
[TBL] [Abstract][Full Text] [Related]
13. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
14. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L
Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.
Guan X; Wang X; Luo H; Wu J; Zhang X; Wu J
Med Sci Monit; 2014 Nov; 20():2269-74. PubMed ID: 25391977
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.
Ghilardi G; Biondi ML; DeMonti M; Turri O; Guagnellini E; Scorza R
Stroke; 2002 Oct; 33(10):2408-12. PubMed ID: 12364729
[TBL] [Abstract][Full Text] [Related]
18. Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis.
Seifi M; Fallah S; Firoozrai M
Arch Med Res; 2009 Oct; 40(7):600-4. PubMed ID: 20082876
[TBL] [Abstract][Full Text] [Related]
19. The 5A Allele of the MMP3-Gene Promoter Polymorphism Is a Risk Factor for Poor Outcome of Hemodialysis Patients.
Dragovic JT; Popovic J; Djuric P; Bulatovic A; Jankovic A; Buzadzic I; Dimkovic N
Tohoku J Exp Med; 2017 Aug; 242(4):273-279. PubMed ID: 28781337
[TBL] [Abstract][Full Text] [Related]
20. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY
J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
